JPRN-UMIN000046686已完成未知
The effect of Dipeptidyl Peptidase 4 inhibitor on the insulin resistance in the Japanese patients with type 2 diabetes - The effect of Dipeptidyl Peptidase 4 inhibitor on the insulin resistance in the Japanese patients with type 2 diabetes
Tottori University Faculty of Medicine0 个研究点目标入组 10 人开始时间: 2022年1月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
improved insulin resistance
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Type 1 diabetes mellitus, pancreatic disease, liver disease, renal failure, or those taking diabetogenic medications such as corticosteroids
研究者
相似试验
已完成
3 期
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2DType 2 DiabetesNCT01937598Michael A. Nauck16
已完成
不适用
Effect of DPP-4 inhibitor on insulin therapy for patients with type 2 diabetesType 2 diabetesJPRN-UMIN000006470Jikei University School of Medicine Kashiwa Hospital20
进行中（未招募）
不适用
ANTIDIABETIC EFFECTS OF ADDING A DPP-4 INHIBITOR (SITAGLIPTIN) TO PRE-EXISTING TREATMENT WITH AN INCRETIN MIMETIC (LIRAGLUTIDE) IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH METFORMITYPE 2 DIABETESMedDRA version: 16.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2013-001764-35-DEDiabeteszentrum Bad Lauterberg
已完成
不适用
Non-alcoholic Fatty Liver Disease and Its TreatmentNAFLDNCT05480007Shanghai 10th People's Hospital68
已完成
4 期
DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart FailureHeart FailureDiabetes MellitusNCT02312427Mitsui Memorial Hospital10